Jeannot, V., Busser, B., Vanwonterghem, L., Michallet, S., Ferroudj, S., Cokol, M., Coll, J., Ozturk, M. & Hurbin, A. (2016) Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma. ONCOTARGETS AND THERAPY , 9(None), 6843-6855.